|
Volumn 15, Issue 9, 2001, Pages 581-585
|
Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori
a a a a a a a a a a a a a a a a |
Author keywords
Bismuth; Helicobacter pylori; Metronidazole; Quadruple therapy; Tetracycline; Treatment
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIULCER AGENT;
BISMUTH CITRATE;
BISMUTH DERIVATIVE;
CARBON 13;
METRONIDAZOLE;
OMEPRAZOLE;
TETRACYCLINE;
UREA;
ADULT;
AGED;
ARTICLE;
BREATH ANALYSIS;
CLINICAL PROTOCOL;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG USE;
DRUG WITHDRAWAL;
DYSPEPSIA;
ERADICATION THERAPY;
FEMALE;
GRAM NEGATIVE INFECTION;
HEADACHE;
HELICOBACTER PYLORI;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IRRITABLE COLON;
MAJOR CLINICAL STUDY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PATIENT SELECTION;
PEPTIC ULCER;
PRIORITY JOURNAL;
SIDE EFFECT;
|
EID: 0035172165
PISSN: 08357900
EISSN: None
Source Type: Journal
DOI: 10.1155/2001/305756 Document Type: Article |
Times cited : (30)
|
References (12)
|